Barclays raised the firm’s price target on Keurig Dr Pepper (KDP) to $30 from $28 and keeps an Equal Weight rating on the shares. The company’s Q1 report tries to make a case for why it should be back on investor radars, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KDP:
- Keurig Dr Pepper price target raised to $33 from $32 at JPMorgan
- Keurig Dr Pepper price target raised to $34 from $32 at UBS
- Keurig Dr Pepper price target raised to $30 from $28 at Evercore ISI
- Keurig Dr Pepper: Solid Execution but Coffee Headwinds and Strategic Uncertainty Justify Hold Rating
- Keurig Dr Pepper: Strong Beverage Momentum and Easing Coffee Costs Support Buy Rating Into 2027